학술논문
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer
Document Type
Article
Author
Source
In: Cancer . (Cancer, 1 March 2023, 129(5):740-749)
Subject
Language
English
ISSN
10970142
0008543X
0008543X